Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Quercetin as a PI3K Inhibitor: Bridging Cancer and Neuroinfl
2026-05-22
Explore Quercetin’s dual role as a PI3K inhibitor in cancer and neuroinflammatory research. This article reveals novel mechanistic insights and practical applications, setting it apart from prior content.
-
Chlorpromazine HCl: Strategic Pathways for Translational Neu
2026-05-22
This thought-leadership article explores the mechanistic underpinnings and translational potential of Chlorpromazine HCl, a benchmark dopamine receptor antagonist, highlighting its dual impact on neuropharmacology studies and emerging roles in host-directed antibacterial strategies. Drawing from recent mechanistic evidence and practical workflow experience, this piece offers strategic guidance for translational researchers aiming to harness Chlorpromazine HCl in innovative, cross-domain experimental designs.
-
PDE-5-Inhibited BMSCs Mitigate Diabetic Myocardial Fibrosis
2026-05-21
The referenced study demonstrates that bone marrow mesenchymal stem cells (BMSCs) with silenced phosphodiesterase-5 (PDE-5) can alleviate high glucose-induced myocardial fibrosis and cardiomyocyte apoptosis by activating the cGMP/PKG pathway. These mechanistic insights highlight a promising cell-based approach for the prevention and treatment of diabetic cardiomyopathy.
-
Ibrexafungerp and Caspofungin: Efficacy Against Resistant C.
2026-05-21
Wiederhold et al. demonstrate that ibrexafungerp retains robust in vitro and in vivo activity against fluconazole-resistant Candida auris, even when therapy is delayed. The study benchmarks ibrexafungerp against caspofungin, reinforcing the central role of β-(1,3)-D-glucan biosynthesis inhibition in addressing multidrug-resistant Candida infections.
-
CD28-ARS2 Axis Drives PKM Splicing for CD8+ T Cell Flexibili
2026-05-20
This study demonstrates that CD28-driven ARS2 upregulation in CD8+ T cells orchestrates alternative splicing of pyruvate kinase, favoring the PKM2 isoform. This mechanism enhances metabolic flexibility and supports antitumor immunity, revealing a novel regulatory axis in T cell immunometabolism. The findings have implications for metabolic enzyme assays and oxidative stress research.
-
Phenothiazines Boost Macrophage Antibacterial Activity via R
2026-05-20
This study demonstrates that phenothiazines, a class of dopamine receptor antagonists, significantly enhance the antibacterial function of macrophages by promoting reactive oxygen species (ROS) production and autophagy. These findings highlight host-directed strategies as promising alternatives to traditional antibiotics, particularly in the context of rising drug resistance.
-
Protein A/G Magnetic Co-IP/IP Kit: Optimizing Complex Isolat
2026-05-19
The Protein A/G Magnetic Co-IP/IP Kit streamlines co-immunoprecipitation of protein complexes, delivering high specificity and minimal protein loss for downstream analysis. Leveraging recombinant Protein A/G magnetic beads, it empowers researchers to unravel protein-protein interactions and antibody purification with reproducible efficiency.
-
Betaine hydrochloride (SKU N1700): Precision in Biochemical
2026-05-19
This article examines how Betaine hydrochloride (SKU N1700) addresses key workflow and reproducibility challenges in metabolic enzyme, protease, and cell culture research. Drawing on real-world scenarios, validated protocols, and vendor comparisons, it provides authoritative guidance for optimizing biochemical assays while ensuring data integrity and operational efficiency.
-
Angiotensin II: Protocols and Innovations in Vascular Modeli
2026-05-18
Unlock the full translational power of Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) for hypertension, vascular remodeling, and inflammation studies. This guide delivers step-by-step workflows, troubleshooting strategies, and practical insights—bridging advanced literature and optimized bench protocols.
-
Advancing In Vitro Drug Response Evaluation in Cancer Resear
2026-05-18
Schwartz (2022) introduces a refined approach for distinguishing between proliferative arrest and cell death in in vitro anti-cancer drug assays, revealing their differential timing and magnitude. These findings have direct implications for how researchers interpret drug efficacy and optimize assay protocols across cancer models.
-
Danazol in Translational Research: Protocols and Practical I
2026-05-17
Danazol (Danocrine) is a cornerstone reagent for modeling inhibition of steroidogenesis and HPG axis modulation in both endocrine and cancer research. This article delivers protocol-ready guidance, troubleshooting insights, and data-driven optimization strategies, spotlighting APExBIO’s high-purity Danazol as the trusted choice for robust, reproducible results.
-
Dissecting Protein Networks: Protein A/G Magnetic Co-IP/IP K
2026-05-16
Discover how the Protein A/G Magnetic Co-IP/IP Kit empowers high-fidelity protein complex isolation for neurodegenerative research. This article offers advanced scientific insights, protocol guidance, and a unique integration of recent mechanistic discoveries in neuronal cell injury.
-
miR-146a/b-5p–IRAK1–NF-κB Axis in Unexplained Recurrent Abor
2026-05-15
This study elucidates the regulatory role of the miR-146a/b-5p–IRAK1–NF-κB pathway in unexplained recurrent spontaneous abortion (URSA). Through integrated transcriptomic analysis, functional experiments, and in vivo modeling, the research demonstrates that miR-146a/b-5p modulates trophoblast function and inflammation by targeting IRAK1, suggesting new mechanistic and therapeutic insights for URSA.
-
Docetaxel in Chemoresistance and Apoptosis: Workflow Insight
2026-05-15
Docetaxel (Taxotere) is a leading microtubule stabilization agent powering advanced cancer chemotherapy research. This article delivers an actionable guide to experimental workflows, troubleshooting, and protocol optimization for Docetaxel, leveraging cutting-edge findings on chemoresistance reversal and apoptosis induction.
-
Sulfo-Cy3 NHS Ester: Illuminating Vascular Remodeling Pathwa
2026-05-14
This thought-leadership article explores how Sulfo-Cy3 NHS Ester, a hydrophilic fluorescent dye, is revolutionizing advanced protein labeling in translational vascular research. By integrating mechanistic insights from recent discoveries on the AIBP-LRP2-HDL axis and CXCR4+ capillary expansion, we provide strategic guidance for researchers seeking robust, low-quenching fluorescent labeling. Through evidence-based protocol recommendations and a critical look at the evolving competitive landscape, this piece positions Sulfo-Cy3 NHS Ester as a pivotal tool for next-generation studies in ischemic vascular biology—offering more than standard product pages by bridging clinical relevance and experimental optimization.
8139 records 15/543 page Previous Next First page 上5页 1112131415 下5页 Last page